New bispecific antibody demonstrates clinical activity in patients with multiple myeloma
byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispe
Updated on: January 12,2024
18

New bispecific antibody demonstrates clinical activity in patients with multiple myeloma
byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispe
Updated on:January 12,2024
18
